Monte Rosa Therapeutics’ Global Licensing Collaboration with Novartis

Leila Ahmed North America Legal Chronicle
Tagged:

Ropes & Gray advised Monte Rosa Therapeutics on the transaction. Monte Rosa Therapeutics (Nasdaq: GLUE) has entered into a global exclusive licensing agreement with Novartis to…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here